Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance - Wikidata - awgldk - TriplyDB

Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance

Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance

http://www.wikidata.org/entity/Q29614354

about

PPARG binding landscapes in macrophages suggest a genome-wide contribution of PU.1 to divergent PPARG binding in human and mouse Modulation of macrophage activation state protects tissue from necrosis during critical limb ischemia in thrombospondin-1-deficient mice Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis Peroxisome Proliferator-Activated Receptor-γ-Mediated Polarization of Macrophages in Leishmania Infection An oxidized lipid-peroxisome proliferator-activated receptor gamma-chemokine pathway in the regulation of macrophage-vascular smooth muscle cell adhesion The chemokine CCL18 causes maturation of cultured monocytes to macrophages in the M2 spectrum Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2.Role of nuclear receptor corepressor RIP140 in metabolic syndrome Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis PPARs and the cardiovascular system Impact of increased adipose tissue mass on inflammation, insulin resistance, and dyslipidemia PPAR-delta senses and orchestrates clearance of apoptotic cells to promote tolerance Is the Mouse a Good Model of Human PPARγ-Related Metabolic Diseases?Exercise and Adipose Tissue Macrophages: New Frontiers in Obesity Research?Novel Action of Carotenoids on Non-Alcoholic Fatty Liver Disease: Macrophage Polarization and Liver Homeostasis Adipose Tissue Remodeling: Its Role in Energy Metabolism and Metabolic Disorders The Macrophage Switch in Obesity Development PPARγ and the Innate Immune System Mediate the Resolution of Inflammation Macrophage Heterogeneity and Plasticity: Impact of Macrophage Biomarkers on Atherosclerosis Control of macrophage metabolism and activation by mTOR and Akt signaling N-3 Polyunsaturated Fatty Acids and Inflammation in Obesity: Local Effect and Systemic Benefit Recent Trends in Therapeutic Approaches for Diabetes Management: A Comprehensive Update Regulating the Intersection of Metabolism and Pathogenesis in Gram-positive Bacteria Roles of Chemokines and Chemokine Receptors in Obesity-Associated Insulin Resistance and Nonalcoholic Fatty Liver Disease Kupffer cells in the liver Macrophages in vascular inflammation--From atherosclerosis to vasculitis Exploiting genomics and natural genetic variation to decode macrophage enhancers Emerging role of mast cells and macrophages in cardiovascular and metabolic diseases I-L-C-2 it: type 2 immunity and group 2 innate lymphoid cells in homeostasis Alternatively activated macrophages in types 1 and 2 diabetes Anti-inflammatory therapy in chronic disease: challenges and opportunities Adipose tissue immunity and cancer Tissue-resident macrophages Mitochondria in the regulation of innate and adaptive immunity Brd2 gene disruption causes "metabolically healthy" obesity: epigenetic and chromatin-based mechanisms that uncouple obesity from type 2 diabetes The immune system's involvement in obesity-driven type 2 diabetes Immunological Profiling of Obesity Macrophage proliferation, provenance, and plasticity in macroparasite infection Regulating the adaptive immune response to respiratory virus infection Nonalcoholic fatty liver disease: new treatments

P2860

Q21133922-6AB2BE98-B1A9-4717-A5C2-C10C9C1E1D52 Q21144122-769F5BE8-52C7-4644-847D-D3D933584022 Q21245469-EA1A191F-A050-4D24-B4D1-CC2CDE743182 Q21284970-B3BD1986-C311-477C-BA03-800337888E7E Q24300694-3789F180-FC3B-4F7A-A315-F92E49E2F2DC Q24606039-0FF5C897-9762-436D-98B2-A49605ED9190 Q24606271-9C501C05-7AB2-492D-ADA1-7D7659BAEC3B Q24610857-5079CCCE-039F-49FC-9A46-F0BC5185099B Q24629044-5844EAA9-CCF8-45CA-BE86-B72BE8A0A423 Q24642728-4AECF467-532C-4DFC-8494-1B9DDA9944E2 Q24645182-7334A0B4-B53C-47D9-9B36-080E337EBE73 Q24650398-380999D7-EF37-419F-B99D-DCDCDC87BF33 Q26739984-5DA037D4-E89E-4041-B6E5-0BC2728EED6F Q26744600-F90A4E7D-D0D0-4E0F-9509-131B3FD93D59 Q26746997-8CAAC883-0362-45FA-8317-C406A8566967 Q26752618-78D6E68E-D4EF-4331-914F-BB6E446510CD Q26771455-6D71A839-F1DF-4389-95E0-CDAD1B37C1E2 Q26771755-C4DE4572-D7DB-48D8-BA24-FFBFCD5D5619 Q26780531-CAAD6A07-B605-4E6B-9259-E5CA20036765 Q26781587-8DE5CB51-588E-4244-AA46-278C09429D58 Q26784504-1867CD22-97A1-4C92-83BA-60FE328ECAA4 Q26798145-3962266E-A66D-42AF-A096-78EB6BC4D765 Q26799806-DB06A510-109D-4293-BA9D-4D7E57B12E29 Q26801371-AD2EFB91-4AF3-4830-BDC9-6036937F71F2 Q26822031-61A5C92C-0935-4533-887A-8564C031A566 Q26825052-EC954287-4FEE-491E-9576-183ACDC0438C Q26825066-FB966D45-1CD7-4FE2-8283-99B268A1BB5B Q26825467-10AFB621-AA70-43B2-AF73-B7FBE2918DFD Q26827479-FC3E0E38-EF8F-415B-869D-8976763D1C5A Q26849454-BCA59D71-7E17-4C72-A9F7-AD1615876B5E Q26860162-BB83C7FE-067F-4587-94B0-CBFD2BA07F28 Q26862654-1F0CB5EF-E2C8-45E1-BA97-0DA488BDF6BE Q26991488-35A85E24-057D-4BC4-8121-CE9D849A2E97 Q26992186-50A9C8B5-F866-4982-88AF-F5742EC36D5D Q26996631-CB354AC8-7913-4576-A8C3-62F367882A51 Q27001164-2DD7ED22-80A7-4272-9464-05A1874AD2E7 Q27003154-001FB772-F022-4609-9418-5D65B707FC4A Q27007951-E6B0E175-B795-4789-BAA3-01B9B4748B61 Q27014696-2744B14E-69FF-427F-B9B0-AEDFD6B5F033 Q27021161-6978D782-6D5C-43DE-B5F7-6F4F83349655

P2860

Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance

http://www.wikidata.org/entity/Q29614354

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Macrophage-specific PPARgamma ...... nd improves insulin resistance

@ast

Macrophage-specific PPARgamma ...... nd improves insulin resistance

@en

type

label

Macrophage-specific PPARgamma ...... nd improves insulin resistance

@ast

Macrophage-specific PPARgamma ...... nd improves insulin resistance

@en

prefLabel

Macrophage-specific PPARgamma ...... nd improves insulin resistance

@ast

Macrophage-specific PPARgamma ...... nd improves insulin resistance

@en

P1433

Q29614354-7D2CDE79-CB6F-41EC-8161-950039787216

P1476

Q29614354-9FB22365-AB0A-4649-901D-3439CE823226

P2093

Q29614354-17D11FB7-D99A-462B-A956-3610D4155CBC

Q29614354-320FE1D0-B9A0-4A4B-BB63-4514F5E9C7E4

Q29614354-4352A037-4322-4F66-8CBE-CB8A761713EC

Q29614354-571543DA-700B-4070-A178-9329F8EDC70C

Q29614354-62383F61-A065-4157-8DC8-4593E87ADFA8

Q29614354-9497807E-4F37-4C5C-AC02-32127AEB0122

Q29614354-ABA558EF-634B-4767-97F7-1D35EA097106

Q29614354-B2309180-4EE8-44EE-A69A-AD182E28CF56

Q29614354-B621D812-45DC-4B21-A220-E7C212489021

Q29614354-E1CC5554-51B8-4B45-889E-44F1B98E891E

P2860

Q29614354-0E4522D8-54F7-4C31-BCB4-340E75D82337

Q29614354-1F48988C-03CD-400A-A6AC-83CE460A9A8F

Q29614354-2049E0F2-1858-4729-A9D3-9119DE70416F

Q29614354-26EC2FD5-69F5-4DC1-887E-5061DFD5F160

Q29614354-2E3C7279-DB2D-40DC-9E24-27F082B7DC88

Q29614354-2FB7E11D-0D36-486B-90A6-EFA3B5CAA7A8

Q29614354-3FF4168F-023E-4923-A874-4EC1D87559A5

Q29614354-468AE38F-0905-4EE4-AE3D-38BD69043768

Q29614354-57260D91-166D-419D-BE00-F9DE28EBF8FA

Q29614354-5DF1B2F9-922E-4BF9-9D3B-6A593E3A24A5

P2888

Q29614354-6A3F4A12-E47A-40B4-94FD-4FEA5AF2A669

P304

Q29614354-A7AF6E63-D94E-49EF-952E-EA8C98A9155A

P31

Q29614354-3A07AE9E-28B4-4C00-A632-2A72D8AB3175

P3181

Q29614354-47CF86CF-FB61-48CC-A3E8-111D5A573C91

P356

Q29614354-11D45874-0E1D-476C-8996-7DFC4BE0C6BC

P407

Q29614354-0036B8D1-712C-46C8-8340-D173866FCAA3

P433

Q29614354-542490AB-47FE-4B4D-877D-EE68CF2E7906

P478

Q29614354-6DD4E7AB-4FD8-419F-A029-A02ED5F6359E

P577

Q29614354-B8192DA2-D59C-4A88-BC35-00189786B2C6

P5875

Q29614354-6CD5E2E2-C4B8-4E09-B6C1-BDC98B634827

P6179

Q29614354-7708CBD9-BD22-4D5B-9802-ADC73DB87591

P698

Q29614354-A224D9F3-1717-48B3-B2A3-98E9F9CBE276

P921

Q29614354-9F082B38-CA40-425F-9906-45BBA88F4BC6

Q29614354-E077B91F-47FE-4D49-BBF4-A716DA3793F6

P932

Q29614354-55E19CB9-9A6E-422D-A95D-B7A4D83E1E03

P3181

P356

P1433

P1476

Macrophage-specific PPARgamma ...... nd improves insulin resistance

@en

P2093

Brombacher F

http://www.w3.org/2001/XMLSchema#string

Chawla A

http://www.w3.org/2001/XMLSchema#string

Ferrante AW

http://www.w3.org/2001/XMLSchema#string

Goforth MH

http://www.w3.org/2001/XMLSchema#string

Morel CR

http://www.w3.org/2001/XMLSchema#string

Mukundan L

http://www.w3.org/2001/XMLSchema#string

Odegaard JI

http://www.w3.org/2001/XMLSchema#string

Red Eagle A

http://www.w3.org/2001/XMLSchema#string

Ricardo-Gonzalez RR

http://www.w3.org/2001/XMLSchema#string

Subramanian V

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammation and insulin resistance

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1

Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation

Inflammation and metabolic disorders

Alternative activation of macrophages

Obesity is associated with macrophage accumulation in adipose tissue

Enhancer-mediated control of macrophage-specific arginase I expression

Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase

PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes

P2888

P304

1116-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

130120

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NATURE05894

http://www.w3.org/2001/XMLSchema#string

P407

P433

7148

http://www.w3.org/2001/XMLSchema#string

P478

447

http://www.w3.org/2001/XMLSchema#string

P577

2007-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6316537

http://www.w3.org/2001/XMLSchema#string

P6179

1050655831

http://www.w3.org/2001/XMLSchema#string

P698

17515919

http://www.w3.org/2001/XMLSchema#string

P921

P932

2587297

http://www.w3.org/2001/XMLSchema#string